long term massive potentials, +20,000%

NASDAQ:PMCB   PharmaCyte Biotech, Inc
PharmaCyte Biotech, Inc. , a biotechnology company, focuses on developing and commercializing cellular therapies for cancer and diabetes in the United States.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.